Workflow
Travere Therapeutics (TVTX) 2025 Conference Transcript

Travere Therapeutics (TVTX) 2025 Conference September 04, 2025 02:45 PM ET Speaker2All right. Hello, everyone. My name is Prakhara Gurwal. I'm a biotech analyst at Cantor. Welcome to day two of Cantor's Global Healthcare Conference. For the next session, we are very excited to host the team of Travere Therapeutics. Representing Travere, we have Eric Dube, President and CEO, and Peter Heerma, Chief Commercial Officer. Gentlemen, thank you for coming.Speaker1Thanks for having us.Speaker2Obviously, a lot going ...